Literature DB >> 23339070

Reducing cost in sequential testing: a limit of indifference approach.

Anwar E Ahmed1, Christine M Schubert, Donna K McClish.   

Abstract

In noninferiority studies, a limit of indifference is used to express a tolerance in results such that the clinician would regard such results as being acceptable or 'not worse'. We applied this concept to a measure of accuracy, the Receiver Operating Characteristic (ROC) curve, for a sequence of tests. We expressed a limit of indifference for the range of acceptable sensitivity values and examined the associated cost of testing within this range. In doing so, we generated the minimum cost maximum ROC (MCMROC) curve, which reflects the reduced sensitivity and cost of testing. We compared the MCMROC and its associated cost curve between limits of indifference set to 0.999 [a 0.1% reduction in true positive rate (TPR)], 0.95 (a 5% reduction in TPR), and 1 (no reduction in TPR). The limit of indifference tended to have less of an effect on the MCMROC curves than on the associated cost curves that were greatly affected. Cost was reduced at high false positive rates (FPRs) at higher limit of indifference (0.999) and at small FPRs as the limit of indifference decreased (0.95). These patterns were also observed as applied to sequential strategies used to diagnose diabetes in the Pima Indians.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23339070     DOI: 10.1002/sim.5741

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  Improving risk prediction for pancreatic cancer in symptomatic patients: a Saudi Arabian study.

Authors:  Anwar E Ahmed; Faris S Alzahrani; Ahmed M Gharawi; Salman A Alammary; Fahad H Almijmaj; Fahad M Alhusayni; Donna K McClish; Hamdan Al-Jahdali; Ashwaq A Al Olayan; Abdul Rahman Jazieh
Journal:  Cancer Manag Res       Date:  2018-10-25       Impact factor: 3.989

2.  Factors associated with recovery delay in a sample of patients diagnosed by MERS-CoV rRT-PCR: A Saudi Arabian multicenter retrospective study.

Authors:  Anwar E Ahmed; Hamdan Al-Jahdali; Mody Alaqeel; Salma S Siddiq; Hanan A Alsaab; Ezzeldin A Sakr; Hamed A Alyahya; Munzir M Alandonisi; Alaa T Subedar; Yosra Z Ali; Hazza Al Otaibi; Nouf M Aloudah; Salim Baharoon; Sameera Al Johani; Mohammed G Alghamdi
Journal:  Influenza Other Respir Viruses       Date:  2018-04-25       Impact factor: 4.380

3.  Development of a risk-prediction model for Middle East respiratory syndrome coronavirus infection in dialysis patients.

Authors:  Anwar E Ahmed; Abeer N Alshukairi; Hamdan Al-Jahdali; Mody Alaqeel; Salma S Siddiq; Hanan A Alsaab; Ezzeldin A Sakr; Hamed A Alyahya; Munzir M Alandonisi; Alaa T Subedar; Nouf M Aloudah; Salim Baharoon; Majid A Alsalamah; Sameera Al Johani; Mohammed G Alghamdi
Journal:  Hemodial Int       Date:  2018-04-14       Impact factor: 1.812

4.  Early identification of pneumonia patients at increased risk of Middle East respiratory syndrome coronavirus infection in Saudi Arabia.

Authors:  Anwar E Ahmed; Hamdan Al-Jahdali; Abeer N Alshukairi; Mody Alaqeel; Salma S Siddiq; Hanan Alsaab; Ezzeldin A Sakr; Hamed A Alyahya; Munzir M Alandonisi; Alaa T Subedar; Nouf M Aloudah; Salim Baharoon; Majid A Alsalamah; Sameera Al Johani; Mohammed G Alghamdi
Journal:  Int J Infect Dis       Date:  2018-03-14       Impact factor: 3.623

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.